Clinical Trial

Efficacy & Safety of Anticoagulants in Cirrhosis ± HCC

Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
We will give an anticoagulant against portal vein thrombosis, and watch for the results.
Trial Details
NCT Number NCT07132515
Lead Sponsor Mansoura University
Conditions Cirrhosis, HCC - Hepatocellular Carcinoma, Portal Vein Thrombosis
Enrollment 100 participants
Start Date 2023-08-15
Primary Completion 2025-08 (estimated)
Study Completion 2025-08 (estimated)
Updated on ClinicalTrials.gov 2025-08-20